Ligand-independent pathway that controls stability of interferon alpha receptor

Department of Animal Biology and Mari Lowe Center for Comparative Oncology Research, School of Veterinary Medicine, University of Pennsylvania, Room 316 Hill Pavilion, 380 S University Avenue, Philadelphia, PA 19104-4539, USA.
Biochemical and Biophysical Research Communications (Impact Factor: 2.28). 04/2008; 367(2):388-93. DOI: 10.1016/j.bbrc.2007.12.137
Source: PubMed

ABSTRACT Ligand-specific negative regulation of cytokine-induced signaling relies on down regulation of the cytokine receptors. Down regulation of the IFNAR1 sub-unit of the Type I interferon (IFN) receptor proceeds via lysosomal receptor proteolysis, which is triggered by ubiquitination that depends on IFNAR1 serine phosphorylation. While IFN-inducible phosphorylation, ubiquitination, and degradation requires the catalytic activity of the Tyk2 Janus kinase, here we found the ligand- and Tyk2-independent pathway that promotes IFNAR1 phosphorylation, ubiquitination, and degradation when IFNAR1 is expressed at high levels. A major cellular kinase activity that is responsible for IFNAR1 phosphorylation in vitro does not depend on either ligand or Tyk2 activity. Inhibition of ligand-independent IFNAR1 degradation suppresses cell proliferation. We discuss the signaling events that might lead to ubiquitination and degradation of IFNAR1 via ligand-dependent and independent pathways and their potential physiologic significance.

Download full-text


Available from: Alexander Plotnikov, Nov 20, 2014
  • Source
    • "Nevertheless, the ligands (i.e., type 1 interferons) elicit a different specific pathway leading to the downregulation of IFNAR1. This pathway is largely dependent on activities of TYK2 and JAK1 [Marijanovic et al., 2006; Liu et al., 2008]. Activated JAKs signal toward IFNAR1 downregulation via stimulating the recruitment of b‐Trcp as a result of increased serine phosphorylation within the IFNAR1 phospho‐degron [Kumar et al., 2004; Marijanovic et al., 2006]. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Activation of cytokine receptor-associated Janus kinases (JAKs) mediates most, if not all, of the cellular responses to peptide hormones and cytokines. Consequently, JAKs play a paramount role in homeostasis and immunity. Members of this family of tyrosine kinases control the cytokine/hormone-induced alterations in cell gene expression program. This function is largely mediated through an ability to signal towards activation of the signal transducer and activator of transcription proteins (STAT) as well as towards some other pathways. Importantly, JAKs are also instrumental in tightly controlling the expression of associated cytokine and hormone receptors, and, accordingly, in regulating the cell sensitivity to these cytokines and hormones. This review highlights the enzymatic and non-enzymatic mechanisms of this regulation and discusses the importance of the ambidextrous nature of JAK as a key signaling node that integrates the combining the functions of forward signaling and eliminative signaling. Attention to the latter aspect of JAK function may contribute to emancipating our approaches to the pharmacologic modulation of JAKs. J. Cell. Biochem. © 2013 Wiley Periodicals, Inc.
    Journal of Cellular Biochemistry 01/2014; 115(1). DOI:10.1002/jcb.24647 · 3.37 Impact Factor
  • Source
    • "Like the TCR and CD4, the IFNRs, particularly IFNGR1, are recruited to lipid rafts upon activation from where they are endocytosed (Claudinon et al., 2007). Recently, a ligand-independent mechanism of IFNAR internalisation and degradation has been reported (Liu et al., 2008). Although phosphorylation and ubiquitination are required, it requires the activity of an as yet unidentified kinase distinct from TYK2. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Although frequently expressed in Epstein-Barr virus (EBV)-positive malignancies, the role that latent membrane protein 2A and 2B (LMP2A and LMP2B) have in the oncogenic process remains obscure. Here we show a novel function for these proteins in epithelial cells, namely, their ability to modulate signalling from type I/II interferon receptors (IFNRs). We show that LMP2A- and LMP2B-expressing epithelial cells show decreased responsiveness to interferon (IFN)alpha and IFNgamma, as assessed by STAT1 phosphorylation, ISGF3 and GAF-mediated binding to IFN-stimulated response element and IFNgamma-activated factor sequence elements and luciferase reporter activation. Transcriptional profiling highlighted the extent of this modulation, with both viral proteins impacting 'globally' on IFN-stimulated gene expression. Although not affecting the levels of cell-surface IFNRs, LMP2A and LMP2B accelerated the turnover of IFNRs through processes requiring endosome acidification. This function may form part of EBV's strategy to limit anti-viral responses and define a novel function for LMP2A and LMP2B in modulating signalling from receptors that participate in innate immune responses.
    Oncogene 09/2009; 28(44):3903-14. DOI:10.1038/onc.2009.249 · 8.56 Impact Factor
  • Source
    • "However, recent evidence suggested the existence of a ligand-and Jak-independent pathway that controls stability of IFNAR1 in a phosphorylation-dependent manner. The importance of the latter pathway remained unclear as it was largely observed under the conditions of IFNAR1 overexpression (Liu et al., 2008). Here we report that this pathway is triggered by activation of the ER stress in a manner that requires function of PERK. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Phosphorylation-dependent ubiquitination and degradation of the IFNAR1 chain of the type I interferon (IFN) receptor is regulated by two different pathways, one of which is ligand independent. We report that this ligand-independent pathway is activated by inducers of unfolded protein responses (UPR), including viral infection, and that such activation requires the endoplasmic reticulum-resident protein kinase PERK. Upon viral infection, activation of this pathway promotes phosphorylation-dependent ubiquitination and degradation of IFNAR1, specifically inhibiting type I IFN signaling and antiviral defenses. Knockin of an IFNAR1 mutant insensitive to virus-induced turnover or conditional knockout of PERK prevented IFNAR1 degradation, whether UPR-induced or virus-induced, and restored cellular responses to type I IFN and resistance to viruses. These data suggest that specific activation of the PERK component of UPR can favor viral replication. Interfering with PERK-dependent IFNAR1 degradation could therefore contribute to therapeutic strategies against viral infections.
    Cell host & microbe 02/2009; 5(1):72-83. DOI:10.1016/j.chom.2008.11.008 · 12.19 Impact Factor
Show more